|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-3-10
|
|
pubmed:abstractText |
To determine the efficacy and safety of pegylated-liposomal doxorubicin in patients with AIDS and Kaposi's sarcoma (AIDS-KS) who experienced failure of standard chemotherapy.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
653-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9053490-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:9053490-Antibiotics, Antineoplastic,
pubmed-meshheading:9053490-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9053490-Disease Progression,
pubmed-meshheading:9053490-Doxorubicin,
pubmed-meshheading:9053490-Drug Carriers,
pubmed-meshheading:9053490-Drug Resistance, Neoplasm,
pubmed-meshheading:9053490-Humans,
pubmed-meshheading:9053490-Liposomes,
pubmed-meshheading:9053490-Male,
pubmed-meshheading:9053490-Polyethylene Glycols,
pubmed-meshheading:9053490-Sarcoma, Kaposi,
pubmed-meshheading:9053490-Treatment Failure,
pubmed-meshheading:9053490-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.
|
|
pubmed:affiliation |
SEQUUS Pharmaceuticals, Inc, Menlo Park, CA, USA. dnorthfelt@pol.net
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study
|
